Thus, the loss of MALAT-1 had minimal effects on pancreatic tumors in transgenic mice where there is activation of Kras and a loss of p53; however, in p53 heterozygote mice, there was an increase (not significant) in survival after loss of MALAT-1 (one or two alleles). This evidence concerns the gene TP53 and pancreatic neoplasm.